AAAAAA

   
Results: 1-12 |
Results: 12
Tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk
Authors: Zheng, Z Park, JY Guillemette, C Schantz, SP Lazarus, P
Citation: Z. Zheng et al., Tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk, J NAT CANC, 93(18), 2001, pp. 1411-1418
Elucidation of CYP2E1 5 ' regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer
Authors: Liu, S Park, JY Schantz, SP Stern, JC Lazarus, P
Citation: S. Liu et al., Elucidation of CYP2E1 5 ' regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer, ORAL ONCOL, 37(5), 2001, pp. 437-445
Metabolizing enzyme genotype and risk for upper aerodigestive tract cancer
Authors: Lazarus, P Park, JY
Citation: P. Lazarus et Jy. Park, Metabolizing enzyme genotype and risk for upper aerodigestive tract cancer, ORAL ONCOL, 36(5), 2000, pp. 421-431
Role of polymorphisms in codons 143 and 160 of the O-6-alkylguanine DNA alkyltransferase gene in lung cancer risk
Authors: Kaur, TB Travaline, JM Gaughan, JP Richie, JP Stellman, SD Lazarus, P
Citation: Tb. Kaur et al., Role of polymorphisms in codons 143 and 160 of the O-6-alkylguanine DNA alkyltransferase gene in lung cancer risk, CANC EPID B, 9(3), 2000, pp. 339-342
Association between glutathione S-transferase pi genetic polymorphisms andoral cancer risk (vol 9, pg 497, 1999)
Authors: Park, JY Schantz, SP Stern, JC Kaur, T Lazarus, P
Citation: Jy. Park et al., Association between glutathione S-transferase pi genetic polymorphisms andoral cancer risk (vol 9, pg 497, 1999), PHARMACOGEN, 10(4), 2000, pp. 371-371
Comparison of GSTM polymorphisms and risk for oral cancer between African-Americans and Caucasians
Authors: Park, JY Muscat, JE Kaur, T Schantz, SP Stern, JC Richie, JP Lazarus, P
Citation: Jy. Park et al., Comparison of GSTM polymorphisms and risk for oral cancer between African-Americans and Caucasians, PHARMACOGEN, 10(2), 2000, pp. 123-131
O-glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by human UDP-glucuronosyltransferases 2B7 and 1A9
Authors: Ren, Q Murphy, SE Zheng, Z Lazarus, P
Citation: Q. Ren et al., O-glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by human UDP-glucuronosyltransferases 2B7 and 1A9, DRUG META D, 28(11), 2000, pp. 1352-1360
Association between glutathione S-transferase pi genetic polymorphisms andoral cancer risk
Authors: Park, JY Schantz, SP Stern, JC Kaur, T Lazarus, P
Citation: Jy. Park et al., Association between glutathione S-transferase pi genetic polymorphisms andoral cancer risk, PHARMACOGEN, 9(4), 1999, pp. 497-504
Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction - Results of the HIT-4 trial
Authors: Neuhaus, KL Molhoek, GP Zeymer, U Tebbe, U Wegscheider, K Schroder, R Camez, A Laarman, GJ Grollier, GR Lok, DJA Kuckuck, H Lazarus, P
Citation: Kl. Neuhaus et al., Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction - Results of the HIT-4 trial, J AM COL C, 34(4), 1999, pp. 966-973
Glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by rat UDP-glucuronosyltransferase 2B1
Authors: Ren, Q Murphy, SE Dannenberg, AJ Park, JY Tephly, TR Lazarus, P
Citation: Q. Ren et al., Glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by rat UDP-glucuronosyltransferase 2B1, DRUG META D, 27(9), 1999, pp. 1010-1016
Society of veterinary assistants?
Authors: Lazarus, P
Citation: P. Lazarus, Society of veterinary assistants?, VET REC, 145(7), 1999, pp. 204-204
A high prevalence of p53 mutations in pre-malignant oral erythroplakia
Authors: Qin, GZ Park, JY Chen, SY Lazarus, P
Citation: Gz. Qin et al., A high prevalence of p53 mutations in pre-malignant oral erythroplakia, INT J CANC, 80(3), 1999, pp. 345-348
Risultati: 1-12 |